What is the morphine equivalent dose of 6 mg of hydromorphone per day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Morphine Equivalent Calculation

This patient's total daily morphine equivalent dose (MME) is 30 MME/day from hydromorphone alone; the T3 (codeine/acetaminophen) contributes an additional 18 MME/day, for a combined total of 48 MME/day. 1

Calculation Breakdown

Hydromorphone Component

  • Daily hydromorphone dose: 6 mg/day
  • CDC conversion factor for hydromorphone: 5.0 1
  • Calculation: 6 mg × 5.0 = 30 MME/day 1

Codeine Component (T3)

  • T3 composition: Each tablet contains codeine 30 mg + acetaminophen 300 mg
  • Daily codeine dose: 4 tablets × 30 mg = 120 mg/day
  • CDC conversion factor for codeine: 0.15 1
  • Calculation: 120 mg × 0.15 = 18 MME/day 1

Total MME

  • Combined daily MME: 30 + 18 = 48 MME/day 1

Clinical Context and Risk Assessment

This patient's total opioid burden of 48 MME/day places them just below the 50 MME/day threshold where the CDC recommends pausing and carefully reassessing benefits versus risks before any further dose escalation. 1

Key Safety Considerations

  • At dosages approaching 50 MME/day, patients experience progressive increases in overdose risk without necessarily experiencing proportional improvements in pain control or function 1
  • Before increasing beyond 50 MME/day, clinicians should pause and carefully reassess individual benefits and risks, as many patients do not experience benefit from higher doses 1
  • Any dosage increases should be by the smallest practical amount 1

Important Caveats About Conversion Factors

The 2022 CDC guideline updated the hydromorphone conversion factor from 4.0 (used in 2016) to 5.0, reflecting more recent evidence about hydromorphone's relative potency. 1

Critical Warnings

  • These conversion factors are specifically for calculating MME for comparison purposes only and should never be used directly when switching patients between opioids 1
  • When actually converting between opioids, the new opioid should be dosed substantially lower (typically 25-50% reduction) than the calculated MME to avoid overdose due to incomplete cross-tolerance 1, 2
  • Equianalgesic conversions are estimates only and cannot account for individual variability in genetics and pharmacokinetics 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid Conversion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.